European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2. Treatment.

[1]  N. Zeitouni,et al.  Immune checkpoint inhibitor therapy in solid organ transplant recipients: A patient-centered systematic review. , 2020, Journal of the American Academy of Dermatology.

[2]  M. Veness,et al.  The role of radiotherapy in the management of non‐melanoma skin cancer , 2019, The Australasian journal of dermatology.

[3]  M. Peters,et al.  Outcomes of Adjuvant Radiotherapy Following Negative Surgical Margins for Cutaneous Squamous Cell Carcinoma. , 2019, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[4]  K. Fung,et al.  Outcomes of Cutaneous Squamous Cell Carcinoma in the Head and Neck Region With Regional Lymph Node Metastasis: A Systematic Review and Meta-analysis , 2019, JAMA otolaryngology-- head & neck surgery.

[5]  D. Brodland,et al.  Clinical outcomes in high‐risk squamous cell carcinoma patients treated with Mohs micrographic surgery alone , 2019, Journal of the American Academy of Dermatology.

[6]  M. Mierzwa.  Radiotherapy for Skin Cancers of the Face, Head, and Neck. , 2019, Facial plastic surgery clinics of North America.

[7]  A. Almeida,et al.  Improved Morphine-Loaded Hydrogels for Wound-Related Pain Relief , 2019, Pharmaceutics.

[8]  A. Wysong,et al.  Cetuximab as a Component of Multimodality Treatment of High-Risk Cutaneous Squamous Cell Carcinoma: A Retrospective Analysis From a Single Tertiary Academic Medical Center , 2019, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[9]  R. Jackson,et al.  Association of Adjuvant Radiation Therapy With Survival in Patients With Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck , 2019, JAMA otolaryngology-- head & neck surgery.

[10]  Sunita Ghosh,et al.  Cetuximab‐radiotherapy combination in the management of locally advanced cutaneous squamous cell carcinoma , 2018, Journal of medical imaging and radiation oncology.

[11]  S. Kerr,et al.  Elective neck dissection in metastatic cutaneous squamous cell carcinoma to the parotid gland: A systematic review and meta‐analysis , 2018, Head & neck.

[12]  A. Kosinski,et al.  Integrated outpatient palliative care for patients with advanced cancer: A systematic review and meta-analysis , 2018, Palliative medicine.

[13]  C. Barker,et al.  Local recurrence and quality of life after adjuvant radiation therapy in high‐risk squamous cell carcinoma , 2018, The British journal of dermatology.

[14]  H. C. de Vijlder,et al.  Recurrence rates of cutaneous squamous cell carcinoma of the head and neck after Mohs micrographic surgery vs. standard excision: a retrospective cohort study , 2018, The British journal of dermatology.

[15]  T. Nijsten,et al.  Needs and preferences of patients regarding basal cell carcinoma and cutaneous squamous cell carcinoma care: a qualitative focus group study , 2018, The British journal of dermatology.

[16]  T. Nijsten,et al.  Isolated limb perfusion for unresectable extremity cutaneous squamous cell carcinoma; an effective limb saving strategy , 2018, British Journal of Cancer.

[17]  J. Gehl,et al.  Electrochemotherapy of unresectable cutaneous tumours with reduced dosages of intravenous bleomycin: analysis of 57 patients from the International Network for Sharing Practices of Electrochemotherapy registry , 2018, Journal of the European Academy of Dermatology and Venereology : JEADV.

[18]  A. Hauschild,et al.  PD‐1 Blockade with Cemiplimab in Advanced Cutaneous Squamous‐Cell Carcinoma , 2018, The New England journal of medicine.

[19]  S. Arron,et al.  Response of Cutaneous Squamous Cell Carcinoma to Treatment With Cetuximab , 2018, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[20]  J. Utikal,et al.  Advanced cutaneous squamous cell carcinoma: A retrospective analysis of patient profiles and treatment patterns-Results of a non-interventional study of the DeCOG. , 2018, European journal of cancer.

[21]  Q. Kan,et al.  Comparison between wait-and-see policy and elective neck dissection in clinically N0 cutaneous squamous cell carcinoma of head and neck , 2018, Medicine.

[22]  J. Lee,et al.  Erlotinib in the treatment of recurrent or metastatic cutaneous squamous cell carcinoma: A single‐arm phase 2 clinical trial , 2018, Cancer.

[23]  L. Borradori,et al.  Application of electrochemotherapy in the management of primary and metastatic cutaneous malignant tumours: a systematic review and meta-analysis , 2018, European Journal of Dermatology.

[24]  I. Proietti,et al.  A Review of the Literature of Surgical and Nonsurgical Treatments of Invasive Squamous Cells Carcinoma , 2018, BioMed research international.

[25]  J. Gehl,et al.  Updated standard operating procedures for electrochemotherapy of cutaneous tumours and skin metastases , 2018, Acta oncologica.

[26]  D. Rischin,et al.  Postoperative Concurrent Chemoradiotherapy Versus Postoperative Radiotherapy in High-Risk Cutaneous Squamous Cell Carcinoma of the Head and Neck: The Randomized Phase III TROG 05.01 Trial. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  N. Hockstein,et al.  Combination of post-operative radiotherapy and cetuximab for high-risk cutaneous squamous cell cancer of the head and neck: A propensity score analysis. , 2018, Oral oncology.

[28]  N. Veeger,et al.  Effective excision of cutaneous squamous cell carcinoma of the face using analysis of intra‐operative frozen sections from the whole specimen , 2018, Journal of surgical oncology.

[29]  B. Mittal,et al.  Guidelines of care for the management of cutaneous squamous cell carcinoma. , 2018, Journal of the American Academy of Dermatology.

[30]  T. Dzierżanowski,et al.  Topical morphine for treatment of cancer-related painful mucosal and cutaneous lesions: a double-blind, placebo-controlled cross-over clinical trial , 2018, Archives of medical science : AMS.

[31]  C. Barker,et al.  Outcomes of radiation therapy for advanced T3/T4 nonmelanoma cutaneous squamous cell and basal cell carcinoma , 2018, The British journal of dermatology.

[32]  Edward S. Kim,et al.  Gefitinib for patients with incurable cutaneous squamous cell carcinoma: A single‐arm phase II clinical trial , 2017, Journal of the American Academy of Dermatology.

[33]  A. Toland,et al.  Epidemiology of keratinocyte carcinomas after organ transplantation , 2017, The British journal of dermatology.

[34]  D. Wood,et al.  An 18‐year retrospective study on the outcomes of keratoacanthomas with different treatment modalities at a single academic centre , 2017, The British journal of dermatology.

[35]  U. Goyal,et al.  Role of Concurrent Systemic Therapy with Adjuvant Radiation Therapy for Locally Advanced Cutaneous Head and Neck Squamous Cell Carcinoma , 2017, Cureus.

[36]  A. Lesokhin,et al.  Immunotherapy of Lymphoma and Myeloma: Facts and Hopes , 2017, Clinical Cancer Research.

[37]  J. Graham,et al.  Efficacy of curettage alone for invasive cutaneous squamous cell carcinoma: A retrospective cohort study , 2017, Journal of the American Academy of Dermatology.

[38]  J. Roodenburg,et al.  Local control of 151 head and neck cutaneous squamous cell carcinoma after radiotherapy: a retrospective study on efficacy and prognostic factors , 2017, Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery.

[39]  E. Velazquez,et al.  Cutaneous Squamous Cell Carcinoma: Review of the Eighth Edition of the American Joint Committee on Cancer Staging Guidelines, Prognostic Factors, and Histopathologic Variants , 2017, Advances in anatomic pathology.

[40]  J. Haumann,et al.  Pain prevalence in cancer patients: status quo or opportunities for improvement? , 2017, Current opinion in supportive and palliative care.

[41]  P. Ascierto,et al.  Electrochemotherapy efficacy evaluation for treatment of locally advanced stage III cutaneous squamous cell carcinoma: a 22-cases retrospective analysis , 2017, Journal of Translational Medicine.

[42]  Levi Garraway,et al.  Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden , 2017, Genome Medicine.

[43]  J. Carucci,et al.  Expression of Programmed Cell Death Ligand in Cutaneous Squamous Cell Carcinoma and Treatment of Locally Advanced Disease With Pembrolizumab , 2017, JAMA dermatology.

[44]  G. Poissonnet,et al.  Association of Oncogenic Mutations in Patients With Advanced Cutaneous Squamous Cell Carcinomas Treated With Cetuximab , 2017, JAMA dermatology.

[45]  R. Wei,et al.  Palliative radiotherapy for skin malignancies. , 2017, Annals of palliative medicine.

[46]  V. Costes,et al.  Efficacy and Tolerance of Cetuximab Alone or Combined with Chemotherapy in Locally Advanced or Metastatic Cutaneous Squamous Cell Carcinoma: An Open Study of 14 Patients , 2017, Dermatology.

[47]  G. Daniels,et al.  Drug therapy of advanced cutaneous squamous cell carcinoma: is there any evidence? , 2017, Current opinion in oncology.

[48]  L. Buchmann,et al.  Elective Neck Dissection for Head and Neck Cutaneous Squamous Cell Carcinoma with Skull Base Invasion , 2017, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[49]  K. May,et al.  Systemic Therapy in Advanced Cutaneous Squamous Cell Carcinoma (CSCC): The Roswell Park Experience and a Review of the Literature , 2016, American journal of clinical oncology.

[50]  A. Hong,et al.  In-Transit Metastasis From Squamous Cell Carcinoma , 2016, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[51]  James A McCaul,et al.  European Research on Electrochemotherapy in Head and Neck Cancer (EURECA) project: Results from the treatment of mucosal cancers. , 2016, European journal of cancer.

[52]  Cathy L Carlson.  Effectiveness of the World Health Organization cancer pain relief guidelines: an integrative review , 2016, Journal of pain research.

[53]  J. Moreno-Giménez,et al.  Neoadjuvant intralesional methotrexate in cutaneous squamous cell carcinoma: a comparative cohort study , 2016, Journal of the European Academy of Dermatology and Venereology : JEADV.

[54]  S. Whitaker,et al.  Non-melanoma skin cancer: United Kingdom National Multidisciplinary Guidelines , 2016, The Journal of Laryngology & Otology.

[55]  R. Senetta,et al.  Squamocellular Carcinoma of the Skin: Clinicopathological Features Predicting the Involvement of the Surgical Margins and Review of the Literature , 2016, Dermatology.

[56]  Nicolai J. Birkbak,et al.  Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade , 2016, Science.

[57]  M. Beylot-Barry,et al.  Complete Remission of Squamous Cell Carcinoma After Treatment With Panitumumab in a Patient With Cetuximab-Induced Anaphylaxis. , 2016, JAMA dermatology.

[58]  R. Dummer,et al.  A prospective clinical trial to assess lapatinib effects on cutaneous squamous cell carcinoma and actinic keratosis , 2016, ESMO Open.

[59]  J. Garioch,et al.  False‐negative rate of intraoperative frozen section margin analysis for complex head and neck nonmelanoma skin cancer excisions , 2015, Clinical and experimental dermatology.

[60]  Jarad Martin,et al.  Outcomes of nodal metastatic cutaneous squamous cell carcinoma of the head and neck treated in a regional center , 2015, Head & neck.

[61]  A. Sidoroff,et al.  European Dermatology Forum guidelines on topical photodynamic therapy , 2015, European Journal of Dermatology.

[62]  I. Zalaudek,et al.  Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline. , 2015, European journal of cancer.

[63]  J. Hafner,et al.  S1 guideline: microscopically controlled surgery (MCS) , 2015, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[64]  C. Robert,et al.  Efficacy of neoadjuvant cetuximab alone or with platinum salt for the treatment of unresectable advanced nonmetastatic cutaneous squamous cell carcinomas , 2015, The British journal of dermatology.

[65]  L. Guenther,et al.  Non-melanoma Skin Cancer in Canada Chapter 4: Management of Basal Cell Carcinoma , 2015, Journal of cutaneous medicine and surgery.

[66]  J. Ashkenas,et al.  Non-melanoma Skin Cancer in Canada Chapter 5: Management of Squamous Cell Carcinoma , 2015, Journal of cutaneous medicine and surgery.

[67]  M. Chren,et al.  Timing of subsequent new tumors in patients who present with basal cell carcinoma or cutaneous squamous cell carcinoma. , 2015, JAMA dermatology.

[68]  F. Simpson,et al.  Phase II study of single-agent panitumumab in patients with incurable cutaneous squamous cell carcinoma. , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

[69]  B. Dréno,et al.  Efficacy of cetuximab in the treatment of squamous cell carcinoma , 2014, The Journal of dermatological treatment.

[70]  N. Lee,et al.  Locally Advanced and Unresectable Cutaneous Squamous Cell Carcinoma: Outcomes of Concurrent Cetuximab and Radiotherapy , 2014, Journal of skin cancer.

[71]  R. Winterhalder,et al.  Cetuximab in Metastatic Squamous Cell Cancer of the Skin: A Swiss Case Series , 2014, Dermatology.

[72]  C. Newlands,et al.  Management of regional metastatic disease in head and neck cutaneous malignancy. 1. Cutaneous squamous cell carcinoma. , 2014, The British journal of oral & maxillofacial surgery.

[73]  C. Newlands,et al.  Management of regional metastatic disease in head and neck cutaneous malignancy. 2. Cutaneous malignant melanoma. , 2014, The British journal of oral & maxillofacial surgery.

[74]  P. Queirolo,et al.  Electrochemotherapy for the management of cutaneous and subcutaneous metastasis: A series of 39 patients treated with palliative intent , 2014, Journal of surgical oncology.

[75]  J. Leonardi-Bee,et al.  Interventions for non-metastatic squamous cell carcinoma of the skin: systematic review and pooled analysis of observational studies , 2013, BMJ.

[76]  R. Leguit,et al.  Post radiation skin tumors: basal cell carcinomas, squamous cell carcinomas and angiosarcomas. A review of this late effect of radiotherapy. , 2013, European journal of dermatology : EJD.

[77]  L. Arends,et al.  Risk of subsequent cutaneous malignancy in patients with prior keratinocyte carcinoma: a systematic review and meta-analysis. , 2013, European journal of cancer.

[78]  A. Hauschild,et al.  Brief S2k guidelines – Cutaneous squamous cell carcinoma , 2013, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[79]  D. Jayne,et al.  SUMMARY OF PRODUCT CHARACTERISTICS , 2014 .

[80]  F. Song,et al.  Risk of a Second Primary Cancer after Non-melanoma Skin Cancer in White Men and Women: A Prospective Cohort Study , 2013, PLoS medicine.

[81]  E. Rosenthal,et al.  Phase 1 study of erlotinib plus radiation therapy in patients with advanced cutaneous squamous cell carcinoma. , 2013, International journal of radiation oncology, biology, physics.

[82]  J. Carucci,et al.  CD200 upregulation in vascular endothelium surrounding cutaneous squamous cell carcinoma. , 2013, JAMA dermatology.

[83]  M. Raftery,et al.  A Surveillance Model for Skin Cancer in Organ Transplant Recipients: A 22‐Year Prospective Study in an Ethnically Diverse Population , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[84]  L. Ciuffreda,et al.  Complete response of metastatic cutaneous squamous cell carcinoma to cetuximab plus paclitaxel. , 2012, European journal of dermatology : EJD.

[85]  E. Dennett,et al.  The incidence of metastasis from cutaneous squamous cell carcinoma and the impact of its risk factors , 2012, Journal of surgical oncology.

[86]  V. Gebski,et al.  Predictors of outcome in patients with metastatic cutaneous head and neck squamous cell carcinoma involving cervical lymph nodes: Improved survival with the addition of adjuvant radiotherapy , 2012, Head & neck.

[87]  V. Gebski,et al.  In patients with metastatic cutaneous head and neck squamous cell carcinoma to cervical lymph nodes, the extent of neck dissection does not influence outcome , 2012, The Journal of Laryngology & Otology.

[88]  M. Chren,et al.  TUMOR RECURRENCE FIVE YEARS AFTER TREATMENT OF CUTANEOUS BASAL CELL CARCINOMA AND SQUAMOUS CELL CARCINOMA , 2012, The Journal of investigative dermatology.

[89]  M. Chambers,et al.  A Phase II Study of Gefitinib for Aggressive Cutaneous Squamous Cell Carcinoma of the Head and Neck , 2012, Clinical Cancer Research.

[90]  K. Bénézery,et al.  Efficacy of cetuximab for unresectable or advanced cutaneous squamous cell carcinoma--a report of eight cases. , 2011, Clinical oncology (Royal College of Radiologists (Great Britain)).

[91]  C Beauvillain,et al.  Guidelines for the diagnosis and treatment of cutaneous squamous cell carcinoma and precursor lesions , 2011, Journal of the European Academy of Dermatology and Venereology : JEADV.

[92]  P. Petrow,et al.  Phase II study of cetuximab as first-line single-drug therapy in patients with unresectable squamous cell carcinoma of the skin. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[93]  B. Diggs,et al.  Outcome of patients treated surgically for lymph node metastases from cutaneous squamous cell carcinoma of the head and neck , 2011, Head & neck.

[94]  Mayte Suárez-Fariñas,et al.  Tumor-associated macrophages in the cutaneous SCC microenvironment are heterogeneously activated. , 2011, The Journal of investigative dermatology.

[95]  Jonathan Clark,et al.  Management of the neck in metastatic cutaneous squamous cell carcinoma of the head and neck , 2011, Current opinion in otolaryngology & head and neck surgery.

[96]  A. Testori,et al.  Electrochemotherapy for cutaneous and subcutaneous tumor lesions: a novel therapeutic approach , 2010, Dermatologic therapy.

[97]  G. Goldman,et al.  Mohs Surgery Is Effective for High‐Risk Cutaneous Squamous Cell Carcinoma , 2010, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[98]  Jonathan R. Clark,et al.  Predicting the pattern of regional metastases from cutaneous squamous cell carcinoma of the head and neck based on location of the primary , 2010, Head & neck.

[99]  K. Woo,et al.  Local Wound Care for Malignant and Palliative Wounds , 2010, Advances in skin & wound care.

[100]  K. Ridd,et al.  Somatic mutation of epidermal growth factor receptor in a small subset of cutaneous squamous cell carcinoma. , 2010, The Journal of investigative dermatology.

[101]  Christopher J. Miller,et al.  Surgical Monotherapy Versus Surgery Plus Adjuvant Radiotherapy in High‐Risk Cutaneous Squamous Cell Carcinoma: A Systematic Review of Outcomes , 2009, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[102]  B. Schönfisch,et al.  Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study. , 2008, The Lancet. Oncology.

[103]  D. Whitaker,et al.  Intralesional methotrexate treatment for keratoacanthoma tumors: a retrospective study and review of the literature. , 2007, Journal of the American Academy of Dermatology.

[104]  R. Collins,et al.  Randomized trial of adjuvant 13-cis-retinoic acid and interferon alfa for patients with aggressive skin squamous cell carcinoma. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[105]  M. Röcken,et al.  A confusing world: what to call histology of three‐dimensional tumour margins? , 2007, Journal of the European Academy of Dermatology and Venereology : JEADV.

[106]  D. Ratner,et al.  What is the role of adjuvant radiotherapy in the treatment of cutaneous squamous cell carcinoma with perineural invasion? , 2007, Cancer.

[107]  C. O'brien,et al.  Patterns of lymph node spread of cutaneous squamous cell carcinoma of the head and neck , 2006, Head & neck.

[108]  C. Palme,et al.  High‐risk cutaneous squamous cell carcinoma of the head and neck , 2006, Cancer.

[109]  Christopher U. Jones,et al.  Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. , 2006, The New England journal of medicine.

[110]  D. Selva,et al.  Cutaneous squamous cell carcinoma treated with Mohs micrographic surgery in Australia I. Experience over 10 years. , 2005, Journal of the American Academy of Dermatology.

[111]  V. Gebski,et al.  Surgery and Adjuvant Radiotherapy in Patients with Cutaneous Head and Neck Squamous Cell Carcinoma Metastatic to Lymph Nodes: Combined Treatment Should be Considered Best Practice , 2005, The Laryngoscope.

[112]  U. Wollina,et al.  Oral capecitabine plus subcutaneous interferon alpha in advanced squamous cell carcinoma of the skin , 2005, Journal of Cancer Research and Clinical Oncology.

[113]  M. Avril,et al.  Immunohistochemical analysis of EGFR and HER-2 in patients with metastatic squamous cell carcinoma of the skin. , 2005, Anticancer research.

[114]  R. Gilbert,et al.  Cutaneous metastatic squamous cell carcinoma to the parotid gland: analysis and outcome , 2004, Head & neck.

[115]  Elizabeth H. Wood,et al.  The National Comprehensive Cancer Network (NCCN). , 2004 .

[116]  B. Coldiron,et al.  In‐Transit Metastasis From Primary Cutaneous Squamous Cell Carcinoma in Organ Transplant Recipients and Nonimmunosuppressed Patients: Clinical Characteristics, Management, and Outcome in a Series of 21 Patients , 2004, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[117]  B. Peat,et al.  Excision Margins for Nonmelanotic Skin Cancer , 2003, Plastic and reconstructive surgery.

[118]  C. Lawrence,et al.  Multiprofessional guidelines for the management of the patient with primary cutaneous squamous cell carcinoma. , 2003, The British journal of dermatology.

[119]  F. Hilgers,et al.  Treatment results of regional metastasis from cutaneous head and neck squamous cell carcinoma. , 2003, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[120]  C. O'brien,et al.  Significance of clinical stage, extent of surgery, and pathologic findings in metastatic cutaneous squamous carcinoma of the parotid gland , 2002, Head & neck.

[121]  Diane D. Liu,et al.  Phase II and biologic study of interferon alfa, retinoic acid, and cisplatin in advanced squamous skin cancer. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[122]  H. Hoekstra,et al.  Educational tips in the treatment of malignant ulcerating tumours of the skin. , 2000, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[123]  F. Mazzoleni,et al.  Oral 5-fluorouracil in squamous cell carcinoma of the skin in the aged. , 2000, American journal of clinical oncology.

[124]  P. Harari,et al.  Epidermal growth factor receptor blockade with C225 modulates proliferation, apoptosis, and radiosensitivity in squamous cell carcinomas of the head and neck. , 1999, Cancer research.

[125]  J. Robinson,et al.  Adjuvant radiotherapy after excision of cutaneous squamous cell carcinoma. , 1994, Journal of the American Academy of Dermatology.

[126]  D. Brodland,et al.  Surgical margins for excision of primary cutaneous squamous cell carcinoma. , 1992, Journal of the American Academy of Dermatology.

[127]  R. Carroll,et al.  Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection. , 1992, Journal of the American Academy of Dermatology.

[128]  M. Luxenberg,et al.  Cisplatin-based chemotherapy in advanced basal and squamous cell carcinomas of the skin: results in 28 patients including 13 patients receiving multimodality therapy. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[129]  D. Goette,et al.  Successful treatment of keratoacanthoma with intralesional fluorouracil. , 1980, Journal of the American Academy of Dermatology.

[130]  Matthew P. Goetz,et al.  NCCN CLINICAL PRACTICE GUIDELINES IN ONCOLOGY , 2019 .

[131]  A. Wysong,et al.  Cisplatin and Cetuximab Treatment for Metastatic Cutaneous Squamous Cell Carcinoma: A Systematic Review , 2017, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[132]  Gregor Sersa,et al.  European Research on Electrochemotherapy in Head and Neck Cancer (EURECA) project: Results of the treatment of skin cancer. , 2016, European journal of cancer.

[133]  D. Brizel,et al.  National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology , 2012 .